Skip to content

Safe-Cross Radio Frequency Total Occlusion Crossing System

by Intra Luminal Therapeutics, Inc. 4 variants

510(k) K033929

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK033929 Date12 Jan 2004ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Modification to Safe-Cross Radio Frequency Total Occlusion Crossing System
510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a wire, guide, or catheter designed for vascular interventions, specifically to facilitate the crossing of total occlusions in native peripheral arteries. It employs radio frequency technology to create a controlled pathway through chronic blockages, enabling subsequent placement of therapeutic or diagnostic devices.

The system is intended for single-use in clinical settings and has received FDA 510(k) clearance under Special Review (K033929) as a Class II device under regulation 870.1330. Sterility and MRI safety are not specified in the data, and no details on reusable components or storage conditions are provided. The modification retains the original system’s intended use for cardiovascular applications.

Other devices from Intra Luminal Therapeutics, Inc.

See all devices from Intra Luminal Therapeutics, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of this device in vascular procedures?

    This device is specifically designed to help physicians cross total occlusions in native peripheral arteries during vascular interventions. It uses radio frequency energy to create a controlled pathway through chronic blockages, allowing subsequent placement of therapeutic or diagnostic tools like stents or catheters.

  • Is this device intended for reuse in clinical settings, or is it meant to be used only once?

    The device is explicitly labeled for single-use in clinical settings, meaning it should not be reused after one procedure. This aligns with standard safety practices for invasive medical devices to prevent contamination or degradation of performance.

  • How was this modification to the original SAFE-CROSS system approved by the FDA?

    The modification received FDA 510(k) clearance under Special Review (K033929) as a Class II device (product code DQX), demonstrating that it was determined to be substantially equivalent to a legally marketed predicate device. The review was conducted by the Cardiovascular (CV) Advisory Committee in 2004.

  • Are there any specific storage instructions provided for this device?

    The provided data does not include details on storage conditions, such as temperature or shelf life. However, since it is a single-use device, it should be stored in its original packaging until use and handled according to standard sterile medical device protocols to maintain integrity.